HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity
ABEC announced it will design, manufacture, and install multiple 4,000L fermenter trains for HEC Pharm’s manufacturing site in Guangzhou, China. The stainless-steel fermenter trains are custom designed to support HEC Pharm’s scale-up initiative of their advanced insulin products.
HEC Pharm is a leader in producing innovative medicines, generics, and biologics. To ensure the highest productivity and product quality, HEC Pharm selected ABEC for its long-term experience in fermenter design and scale up. ABEC has successfully delivered thousands of customized bioreactor and fermentation solutions for over 45 years. ABEC’s 32,000m2 of manufacturing space, the largest global capacity in the industry, also ensures timely delivery to meet HEC Pharm’s rapid time to market needs.
“HEC Pharm is committed to bringing high-quality advanced insulin products to the global market,” said Richard Tang, President of HEC R&D Center. “We are now able to seamlessly scale up from existing processes, which is critical to our plans for continuous growth.”
“ABEC has supported the rapid growth of China’s biotech industry for over ten years,” said Scott Pickering, ABEC CEO and Chairman. “We value the opportunity to work with HEC Pharm as they strive to bring essential medicines to a larger global market.”